Carvacrol
Evidence status
Limited evidence to recommend for any consumer outcome yet.
2 papers · 0 claims · 10 outcomes scored
Risk profile
Adverse events and known drug interactions
Safety events
mortality/weakness in co-treatment group severe
Drug interactions
Thalidomide major increases toxicity
Cyclophosphamide major decreases effect
Cisplatin moderate decreases effect
Cefixime moderate increases effect
Sorafenib moderate increases effect
Haloperidol moderate decreases effect
Sources
Generated August 14, 2026